1. Home
  2. MOLN vs QBTS Comparison

MOLN vs QBTS Comparison

Compare MOLN & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • QBTS
  • Stock Information
  • Founded
  • MOLN 2004
  • QBTS 1999
  • Country
  • MOLN Switzerland
  • QBTS Canada
  • Employees
  • MOLN N/A
  • QBTS N/A
  • Industry
  • MOLN
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • MOLN
  • QBTS Technology
  • Exchange
  • MOLN Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • MOLN 192.4M
  • QBTS 1.4B
  • IPO Year
  • MOLN 2021
  • QBTS N/A
  • Fundamental
  • Price
  • MOLN $5.04
  • QBTS $5.67
  • Analyst Decision
  • MOLN
  • QBTS Strong Buy
  • Analyst Count
  • MOLN 0
  • QBTS 6
  • Target Price
  • MOLN N/A
  • QBTS $6.38
  • AVG Volume (30 Days)
  • MOLN 5.7K
  • QBTS 98.8M
  • Earning Date
  • MOLN 03-13-2025
  • QBTS 03-27-2025
  • Dividend Yield
  • MOLN N/A
  • QBTS N/A
  • EPS Growth
  • MOLN N/A
  • QBTS N/A
  • EPS
  • MOLN N/A
  • QBTS N/A
  • Revenue
  • MOLN $7,105,397.00
  • QBTS $9,424,000.00
  • Revenue This Year
  • MOLN N/A
  • QBTS $4.86
  • Revenue Next Year
  • MOLN $29.41
  • QBTS $64.04
  • P/E Ratio
  • MOLN N/A
  • QBTS N/A
  • Revenue Growth
  • MOLN N/A
  • QBTS 14.27
  • 52 Week Low
  • MOLN $3.32
  • QBTS $0.75
  • 52 Week High
  • MOLN $12.70
  • QBTS $11.41
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 41.97
  • QBTS 47.95
  • Support Level
  • MOLN $5.22
  • QBTS $5.39
  • Resistance Level
  • MOLN $5.35
  • QBTS $6.39
  • Average True Range (ATR)
  • MOLN 0.12
  • QBTS 0.78
  • MACD
  • MOLN -0.03
  • QBTS -0.12
  • Stochastic Oscillator
  • MOLN 0.00
  • QBTS 56.47

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company's LeapTM cloud service.

Share on Social Networks: